Login/Sign Up
Eltrompact 50 Tablet 14's belongs to the class of 'platelet-stimulating agents' primarily used to treat low blood platelet count in patients with idiopathic thrombocytopenic purpura (ITP) and hepatitis C virus (HCV) infections. Eltrompact 50 Tablet 14's is also used to treat severe aplastic anaemia (SAA) in adults. Idiopathic thrombocytopenic purpura is an immune condition associated with low levels of platelets. Hepatitis C is an infection and inflammation of the liver caused due to hepatitis C virus. Severe aplastic anaemia is a condition in which the bone marrow doesn't make enough blood cells.
Eltrompact 50 Tablet 14's contains 'Eltrombopag' which belongs to the class of 'thrombopoietin receptor agonists'. Thrombopoietin is a glycoprotein hormone that stimulates the formation of megakaryocytes (large bone marrow cells) and further regulates platelet's production. Eltrompact 50 Tablet 14's works by increasing these large bone marrow cells responsible for the production of platelets. Thus, Eltrompact 50 Tablet 14's helps increase these bone marrow cells, thereby stimulating the number of platelets, which further lowers the risk of bleeding.
Take Eltrompact 50 Tablet 14's as prescribed by your doctor. In some cases, Eltrompact 50 Tablet 14's can cause common side effects like nausea, diarrhoea, headache, muscle pain, tiredness, loss of appetite, fever, anaemia (lack of blood cells), cough and tingling numbness. These side effects are not familiar to everyone who take Eltrompact 50 Tablet 14's and vary individually. If you notice any side effects that are not manageable, please consult your doctor.
Let your doctor know if you have any allergic reactions to Eltrompact 50 Tablet 14's or any other medicines, before starting Eltrompact 50 Tablet 14's. It is essential to inform your doctor if you have any heart, kidney or liver problems, blood disorders, blood clotting problems and cataracts before starting Eltrompact 50 Tablet 14's. It is advised to consult the doctor if you are pregnant or planning to conceive. Eltrompact 50 Tablet 14's is not indicated for use in breastfeeding since it passes into the breast milk. Eltrompact 50 Tablet 14's may make you dizzy, hence drive or operate machinery only when you are mentally alert.
Eltrompact 50 Tablet 14's contains 'Eltrombopag,' which belongs to the class of 'thrombopoietin receptor agonists' used to treat low blood platelet count in patients with immune (idiopathic) thrombocytopenic purpura (ITP), hepatitis C virus (HCV) infections and severe aplastic anaemia (SAA) in adults. Eltrompact 50 Tablet 14's works by increasing megakaryocytes, the large bone marrow cells responsible for the production of platelets. The increase in these bone marrow cells stimulates the production of platelets. Thus Eltrompact 50 Tablet 14's prevents bleeding episodes by increasing the number of platelets in the blood.
If you are known to be allergic to Eltrompact 50 Tablet 14's or other medicines, please inform your doctor in advance. Brief your medical history if you have blood clots, clotting disorders (Factor V Leiden), blood disorders like blood cancer, myelodysplastic syndrome, cataracts, liver or kidney diseases before starting Eltrompact 50 Tablet 14's. Take Eltrompact 50 Tablet 14's at least two hours before or four hours after consuming antacids, mineral and vitamin supplements (iron, calcium, magnesium, aluminium, selenium and zinc), dairy products, calcium-enriched foods and fortified juices since they interfere with the absorption of Eltrompact 50 Tablet 14's. Eltrompact 50 Tablet 14's is not recommended during pregnancy since it may have harmful effects on the foetus. Consult your doctor before using Eltrompact 50 Tablet 14's if you are a breastfeeding mother. Do not drive or operate machinery since Eltrompact 50 Tablet 14's may cause side effects like dizziness and tiredness, affecting your ability to concentrate and drive. Avoid or limit alcohol consumption with Eltrompact 50 Tablet 14's as it may affect the efficacy of Eltrompact 50 Tablet 14's. Eltrompact 50 Tablet 14's is not recommended for children less than one year of age in ITP and children less than two years of age in SAA.
Drug-Drug Interaction: Eltrompact 50 Tablet 14's may interact with antacids, cholesterol-lowering drugs (statins), vitamin and mineral supplements (iron, calcium, magnesium, aluminium, selenium and zinc), anti-cancer drugs (methotrexate, topotecan), drugs for rheumatoid arthritis (ciclosporin, azathioprine), HIV/AIDS drugs (lopinavir, ritonavir), corticosteroids, and steroid hormones (danazol).
Drug-Food Interaction: Take Eltrompact 50 Tablet 14's at least two hours before or four hours after consuming dairy products, calcium-enriched foods, and fortified juices since they interfere with the absorption of Eltrompact 50 Tablet 14's.
Drug-Disease Interaction: People with blood clots, clotting disorders (Factor V Leiden), blood disorders like blood cancer, myelodysplastic syndrome, cataracts, and liver or kidney diseases should consult the doctor before taking Eltrompact 50 Tablet 14's.
Immune (idiopathic) thrombocytopenic purpura (ITP): It is an immune condition associated with low levels of platelets, and the blood doesn't clot normally. It occurs when the immune system mistakenly attacks its own platelets. ITP also occurs in children, followed by a viral infection. Symptoms of ITP may include easy bruising, bleeding from gums and nose, blood in urine and stools, heavy menstrual flow and pinpoint-sized reddish-purple spots on the lower legs.
Hepatitis C: It is an infection and inflammation of the liver caused due to hepatitis C virus. This virus can cause both acute and chronic hepatitis. Acute hepatitis C is a short term illness that may range for six months. Chronic hepatitis C is a long-lasting disease that may lead to other severe liver cancer problems or cirrhosis (inflammation of the liver). Symptoms of hepatitis C include fatigue, nausea, loss of appetite and yellowing of the eyes and skin.
Severe aplastic anaemia (SAA): Aplastic anaemia is also called bone marrow aplasia. It is a condition in which the bone marrow doesn't make enough blood cells. SAA is commonly caused due to the damage of bone marrow. This damage can be a congenital disability or may occur because of radiation, chemotherapy, toxic chemicals, certain drugs and infections. Symptoms of SAA include fatigue, frequent infections, rapid heart rate and bleeding.
About Eltrompact 50 Tablet 14's
Eltrompact 50 Tablet 14's belongs to the class of 'platelet-stimulating agents' primarily used to treat low blood platelet count in patients with idiopathic thrombocytopenic purpura (ITP) and hepatitis C virus (HCV) infections. Eltrompact 50 Tablet 14's is also used to treat severe aplastic anaemia (SAA) in adults. Idiopathic thrombocytopenic purpura is an immune condition associated with low levels of platelets. Hepatitis C is an infection and inflammation of the liver caused due to hepatitis C virus. Severe aplastic anaemia is a condition in which the bone marrow doesn't make enough blood cells.
Eltrompact 50 Tablet 14's contains 'Eltrombopag' which belongs to the class of 'thrombopoietin receptor agonists'. Thrombopoietin is a glycoprotein hormone that stimulates the formation of megakaryocytes (large bone marrow cells) and further regulates platelet's production. Eltrompact 50 Tablet 14's works by increasing these large bone marrow cells responsible for the production of platelets. Thus, Eltrompact 50 Tablet 14's helps increase these bone marrow cells, thereby stimulating the number of platelets, which further lowers the risk of bleeding.
Take Eltrompact 50 Tablet 14's as prescribed by your doctor. In some cases, Eltrompact 50 Tablet 14's can cause common side effects like nausea, diarrhoea, headache, muscle pain, tiredness, loss of appetite, fever, anaemia (lack of blood cells), cough and tingling numbness. These side effects are not familiar to everyone who take Eltrompact 50 Tablet 14's and vary individually. If you notice any side effects that are not manageable, please consult your doctor.
Let your doctor know if you have any allergic reactions to Eltrompact 50 Tablet 14's or any other medicines, before starting Eltrompact 50 Tablet 14's. It is essential to inform your doctor if you have any heart, kidney or liver problems, blood disorders, blood clotting problems and cataracts before starting Eltrompact 50 Tablet 14's. It is advised to consult the doctor if you are pregnant or planning to conceive. Eltrompact 50 Tablet 14's is not indicated for use in breastfeeding since it passes into the breast milk. Eltrompact 50 Tablet 14's may make you dizzy, hence drive or operate machinery only when you are mentally alert.
₹8400*
₹7140*
MRP ₹8400
15% CB
₹1260 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Online payment accepted
Provide Delivery Location
Available Offers
Country of origin
Manufacturer/Marketer address
Eltrompact 50 Tablet 14's contains Eltrombopag that stimulates platelet's production (helps in clotting) from megakaryocytes (bone marrow cells). Thus Eltrompact 50 Tablet 14's lowers the risk of bleeding episodes in diseases like immune (idiopathic) thrombocytopenic purpura (ITP), hepatitis C virus (HCV) infections and severe aplastic anaemia (SAA).
Do not stop using Eltrompact 50 Tablet 14's even if you feel better. It should be strictly used as advised by your doctor to avoid the recurrence of symptoms and worsening of the disease.
Eltrompact 50 Tablet 14's should be used with caution and only under doctor's supervision in cases of any allergic reactions, blood clots, clotting disorders (Factor V Leiden), blood disorders like blood cancer, myelodysplastic syndrome, cataracts, liver or kidney diseases.
Eltrompact 50 Tablet 14's decreases the risk of bleeding by increasing the platelet count in your body. However, you are advised to stay away from activities that may increase your risk of bleeding like contact sports and using sharp objects like razors and nail cutters.
It is advised to take Eltrompact 50 Tablet 14's on an empty stomach. Please take Eltrompact 50 Tablet 14's at least two hours before or four hours after consuming antacids, mineral and vitamin supplements (iron, calcium, magnesium, aluminium, selenium and zinc), dairy products, calcium-enriched foods and fortified juices since they interfere with the absorption of Eltrompact 50 Tablet 14's.
Alcohol
Caution
Limit alcohol intake, along with Eltrompact 50 Tablet 14's, to attain the maximum efficacy of Eltrompact 50 Tablet 14's and rule out any possibility of worsening of side effects.
Pregnancy
Unsafe
Eltrompact 50 Tablet 14's is not recommended in pregnancy. It may affect and harm the developing baby. Please consult your doctor if you are pregnant or planning to conceive.
Breast Feeding
Caution
It is not known if Eltrompact 50 Tablet 14's is excreted into the breast milk. Please consult your doctor for more information before taking Eltrompact 50 Tablet 14's if you are a nursing mother.
Driving
Caution
Eltrompact 50 Tablet 14's may cause dizziness and tiredness affecting your ability to concentrate and drive. Hence, it is recommended not to drive or operate machinery until you are mentally alert.
Liver
Caution
Let your doctor know if you have any history of liver diseases before taking Eltrompact 50 Tablet 14's. Eltrompact 50 Tablet 14's may cause an increase in liver enzymes. Your doctor may start the treatment with a lower dose of Eltrompact 50 Tablet 14's.
Kidney
Caution
Eltrompact 50 Tablet 14's should be used with caution in cases of renal impairment. It is advised to seek doctor advice before starting Eltrompact 50 Tablet 14's if you have any kidney problems.
Children
Caution
Eltrompact 50 Tablet 14's is not recommended for children less than one year of age in ITP and children less than two years of age in SAA.
Product Substitutes
We provide you with authentic, trustworthy and relevant information
Uses of Eltrompact 50 Tablet 14's
Medicinal Benefits
Eltrompact 50 Tablet 14's contains 'Eltrombopag,' which belongs to the class of 'thrombopoietin receptor agonists' used to treat low blood platelet count in patients with immune (idiopathic) thrombocytopenic purpura (ITP), hepatitis C virus (HCV) infections and severe aplastic anaemia (SAA) in adults. Eltrompact 50 Tablet 14's works by increasing megakaryocytes, the large bone marrow cells responsible for the production of platelets. The increase in these bone marrow cells stimulates the production of platelets. Thus Eltrompact 50 Tablet 14's prevents bleeding episodes by increasing the number of platelets in the blood.
Side Effects of Eltrompact 50 Tablet 14's
Directions for Use
Storage
Drug Warnings
If you are known to be allergic to Eltrompact 50 Tablet 14's or other medicines, please inform your doctor in advance. Brief your medical history if you have blood clots, clotting disorders (Factor V Leiden), blood disorders like blood cancer, myelodysplastic syndrome, cataracts, liver or kidney diseases before starting Eltrompact 50 Tablet 14's. Take Eltrompact 50 Tablet 14's at least two hours before or four hours after consuming antacids, mineral and vitamin supplements (iron, calcium, magnesium, aluminium, selenium and zinc), dairy products, calcium-enriched foods and fortified juices since they interfere with the absorption of Eltrompact 50 Tablet 14's. Eltrompact 50 Tablet 14's is not recommended during pregnancy since it may have harmful effects on the foetus. Consult your doctor before using Eltrompact 50 Tablet 14's if you are a breastfeeding mother. Do not drive or operate machinery since Eltrompact 50 Tablet 14's may cause side effects like dizziness and tiredness, affecting your ability to concentrate and drive. Avoid or limit alcohol consumption with Eltrompact 50 Tablet 14's as it may affect the efficacy of Eltrompact 50 Tablet 14's. Eltrompact 50 Tablet 14's is not recommended for children less than one year of age in ITP and children less than two years of age in SAA.
Therapeutic Class
Drug-Drug Interactions
Login/Sign Up
Drug-Drug Interactions Checker List
Diet & Lifestyle Advise
Habit Forming
Special Advise
Disease/Condition Glossary
Immune (idiopathic) thrombocytopenic purpura (ITP): It is an immune condition associated with low levels of platelets, and the blood doesn't clot normally. It occurs when the immune system mistakenly attacks its own platelets. ITP also occurs in children, followed by a viral infection. Symptoms of ITP may include easy bruising, bleeding from gums and nose, blood in urine and stools, heavy menstrual flow and pinpoint-sized reddish-purple spots on the lower legs.
Hepatitis C: It is an infection and inflammation of the liver caused due to hepatitis C virus. This virus can cause both acute and chronic hepatitis. Acute hepatitis C is a short term illness that may range for six months. Chronic hepatitis C is a long-lasting disease that may lead to other severe liver cancer problems or cirrhosis (inflammation of the liver). Symptoms of hepatitis C include fatigue, nausea, loss of appetite and yellowing of the eyes and skin.
Severe aplastic anaemia (SAA): Aplastic anaemia is also called bone marrow aplasia. It is a condition in which the bone marrow doesn't make enough blood cells. SAA is commonly caused due to the damage of bone marrow. This damage can be a congenital disability or may occur because of radiation, chemotherapy, toxic chemicals, certain drugs and infections. Symptoms of SAA include fatigue, frequent infections, rapid heart rate and bleeding.
by Others
by Others
by Others
by Others
by Others